Effect Of Drug Administration By Nasal Route In Cervical Spondylosis

A COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFECT OF MAHANARYAN TAIL NASYA AND MAHAMASHA TAIL NASYA IN THE MANAGEMENT OF VISHWACHI (CERVICAL SPONDYLOSIS WITH RADICULOPATHY)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031572

Enrollment

Registered

2021-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: MAHA MASH TAIL NASYA 16 BINDU IN EACH NOSTRIL FOR 15 DAYS: MAHA MASHA TAIL NASYA 16 BINDU IN EACH NOSTRIL FOR 15 DAYS Control Intervention1: MAHA NARYAN TAIL NASYA 16 BINDU EACH NOSTRIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of both genders between the age group of 30-60yrs of age. 2. Radiological evidence of Cervical Spondylosis essentially having lesion in C5, C6,C7 3. Patients having signs and symptoms of Vishwachi. 4. Patients indicted for nasya

Exclusion criteria

Exclusion criteria: 1. Acute or chronic infection of spine. 2. Cancer of cervical spine. 3. Any other form of arthritis like Rheumatoid arthritis, SLE 4. Patients contra indicated for Nasya

Design outcomes

Primary

Measure	Time frame
improve sensory and motor function accordingTimepoint: 15 DAYS	—

Secondary

Measure	Time frame
Reduce degree of disability according to Neck Disability Index and improve sensory and motor function according to Japnese Orthopaedic Association.Timepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactDR AARTI

CBPACS

VISHAKHAWETAL@GMAIL.COM9850804498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026